Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, Vol 25, No 8 (March 10), 2007: pp. 996-1002
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.09.7436

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Publisher's Note
Right arrow Erratum (v25,p3561)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanders, M. E.
Right arrow Articles by Li, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanders, M. E.
Right arrow Articles by Li, B. D.

REVIEW ARTICLE

Accelerated Partial Breast Irradiation in Early-Stage Breast Cancer

Mary Ella Sanders, Troy Scroggins, Federico L. Ampil, Benjamin D. Li

From the Departments of Surgery and Radiology, Division of Radiation Oncology, LA State University Health Sciences Center, Shreveport; and the Department of Radiation Oncology, Ochsner Health System, New Orleans, LA

Address reprint requests to Benjamin D. Li, MD, FACS, Louisiana State University Health Sciences Center and the Feist-Weiller Cancer Center, 1501 Kings Highway, Shreveport, LA 71130; e-mail: bli{at}lsuhsc.edu

Whole-breast irradiation, as part of breast-conservation therapy (BCT), has well-established results, good cosmesis, and low toxicity. Results from the BCT trials suggest that the risk for ipsilateral breast cancer recurrence resides within close proximity to the original tumor site. This leads investigators to consider the role of an accelerated and more tumor bed–focused course of radiotherapy. Accelerated partial-breast irradiation (APBI) involves treating a limited volume of breast tissue, with dose of irradiation per fraction increased and the treatment time course decreased. Four currently available methods of APBI are interstitial brachytherapy, intracavitary brachytherapy, intraoperative radiotherapy, and three-dimensional conformal external-beam radiotherapy. Patient selection is critical. This review article presents some preliminary clinical observations and limitations that suggest a potential role for APBI as a more user-friendly mode for delivering radiotherapy after lumpectomy for early breast cancer.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.




This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
J. Godinez, E. C. Gombos, S. A. Chikarmane, G. K. Griffin, and R. L. Birdwell
Breast MRI in the Evaluation of Eligibility for Accelerated Partial Breast Irradiation
Am. J. Roentgenol., July 1, 2008; 191(1): 272 - 277.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. S. Lawrence, N. J. Petrelli, B. D. Li, and J. M. Galvin
Think Globally, Act Locally
J. Clin. Oncol., March 10, 2007; 25(8): 921 - 923.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online